A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/22/2006	CN1285333C Colon target releasing oral preparation and its preparing method
11/22/2006	CN1285332C Ginkgo keto-ester soft capsules with long stable effect and preparation thereof
11/22/2006	CN1285288C Amylose, polypeptide functional blueberry drink and production process
11/22/2006	CN1285277C Production of powdery lipoid
11/21/2006	US7138547 Antitumoral compounds
11/21/2006	US7138546 Compounds and compositions for delivering active agents
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138542 Administering a therapeutically effective amount of an alpha2delta ligand other than gabapentin or tiagabine, or pharmaceutically acceptable salt thereof
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138531 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138529 e.g., N-(3-Cyano-4,5-dimethyl-thiophen-2-yl)-2,2-diphenyl-acetamide;3-Methyl-2-phenyl-pentanoic acid-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-amide; or N-(3-Cyano-6-methanesulfonyl-4,5,6,7-tetrahydro-thieno [2,3-c]pyridin-2-yl)-2,2-diphenyl-acetamide;
11/21/2006	US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/21/2006	US7138521 Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor
11/21/2006	US7138520 Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
11/21/2006	US7138519 Process for extraction of β-glucan from cereals and products obtained therefrom
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138507 primers for amplification of GST-pi mRNA in fixed and paraffin-embedded (FPE) tumor tissue; use in pharmacogenetics
11/21/2006	US7138505 of given sequence, for the preparation of human Factor VIIIC, which is absent or defective in individuals with the hereditary bleeding disorder hemophilia A; host cells and expression vectors
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006	US7138490 of polyethylene glycols and polylactams with an impurities content of not more than 10% by weight; complex of polymer and an anthracycline anticancer drug, such as doxorubicin
11/21/2006	US7138486 Insulinotropic hormone derivatives and uses thereof
11/21/2006	US7138433 Treating liver disease with menatetrerone for treating liver disorders and with descarboxy prothrombin
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138431 Dietary control of arachidonic acid metabolism
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138429 Flavonoid compound and process for producing the same
11/21/2006	US7138428 Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same
11/21/2006	US7138427 Cognition activators
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138421 Anti-androgenic pyrrolidines with tumor-inhibiting action
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138419 Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
11/21/2006	US7138418 Pentafluorobenzenesulfonamides and analogs
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138414 Antidiabetic agents
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138412 For therapy of thromboembolic and/or inflammatory disorders
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor
11/21/2006	US7138409 Heterocyclic compounds
11/21/2006	US7138408 Beta-carboline hydroxamic acid derivatives, used to treat AIDS and AIDS-related complex
11/21/2006	US7138407 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138405 Pharmaceutical combinations
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138401 9-(Substituted phenyl or pyridyl)methyl-2-amino-6-halopurines, e.g., 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138398 Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138395 Interleukin-1β converting enzyme inhibitors
11/21/2006	US7138394 Vehicle for topical delivery of anti-inflammatory compounds
11/21/2006	US7138393 Biologically active vasopressin agonist metabolites
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138391 Water-dispersible IR-absorbing phthalocyanine dyes in which the benzene rings are fused to pyridine or pyrazine rings, suitable for use in inkjet inks
11/21/2006	US7138390 3 alpha ,7 alpha -dihydroxy-6 alpha -ethyl-5 beta -cholan-24-oic acid and salts, solvates or amino acid conjugates thereof; treatment of a farnesoid X receptor mediated disease such as hypercholesteremia, hyperlipidemia, low HDL-cholesterol, and high triglycerides
11/21/2006	US7138389 Oral androgen therapy using modulators of testosterone bioavailability
11/21/2006	US7138388 Methods to treat autoimmune and inflammatory conditions
11/21/2006	US7138387 Clear aqueous composition comprising propofol and hydroxypropyl-beta-cyclodextrin
11/21/2006	US7138386 Preventives or remedies for arthritis
11/21/2006	US7138385 Thioarabinofuranosyl compounds and use thereof
11/21/2006	US7138384 Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
11/21/2006	US7138383 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity
11/21/2006	US7138382 Compositions and methods for drug delivery using pH sensitive molecules
11/21/2006	US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
11/21/2006	US7138379 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
11/21/2006	US7138377 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138148 Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia
11/21/2006	US7138147 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
11/21/2006	US7138146 Acrochordon alleviation
11/21/2006	US7138143 Coated preparation soluble in the lower digestive tract
11/21/2006	US7138142 Producing isoleucine, leucine and valine containing particles having reduced bitterness and odor; small volume dose
11/21/2006	US7138141 Atomizing proteins, nucleic acids, or polysaccharides to form microstructure drops used as inhalants; drug delivery
11/21/2006	US7138138 Pharmaceutical formulation having a masked taste and method for the production thereof
11/21/2006	US7138137 Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
11/21/2006	US7138135 blend of anionic and nonionic water soluble hydroxyl functionalized polymer; pH insensitivity
11/21/2006	US7138134 Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
11/21/2006	US7138133 Orally administered liquid compositions
11/21/2006	US7138122 Therapeutic systems
11/21/2006	US7138113 Glycoprotein matrix compositions and methods related thereto
11/21/2006	US7138107 Inhibition of olfactory neurosensory function to treat eating disorders and obesity
11/21/2006	US7138106 Compositions for use in embolizing blood vessels
11/21/2006	CA2511750C Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2338753C Medicinal aerosol formulations
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2327693C Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
11/21/2006	CA2318260C Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis

1 ... 4001 4002 4003 4004 4005 4006 4007 4008 4009 4010 4011 4012 4013 4014 4015 4016 4017 4018 4019 4020 4021 ... 7860